Development and Evaluation of Microemulsion Formualatons of Valsartan for Solubility Enhancement
Abstract
Microemulsions have attracted considerable amount of interest as potential drug delivery vehicles largely due to their simple method of preparation, stability and their abilities to incorporate a wide range of drugs of varying solubility. O/W microemulsion is expected to increase the solubility by dissolving low water solubility compounds into its dispersed phase and to enhance the oral bioavailability by protecting the drug increasing the rate of absorption and wettability due to surfactants induced permeability changes and smaller droplet size (< 100 nm) and most importantly able to target lymphatic system.
In the present study, the drug delivery system contains Valsartan, a hydrophilic component, a lipophillic component, surfactants and co-surfactants. The objective is to provide an increased release of valsartan and increased bioavailability of valsartan. Prepared microemulsion formulations by phase-titration method were evaluated for viscosity, drug content, thermodynamic stability studies and in-vitro dissolution. Resultant microemulsion optimized formulation (ME5) shows drug release (88.2±0.16%.%). Hence, micro-emulsion of valsartan was successfully developed and evaluated.
Keywords: Microemulsion, Valsartan, solubility, evaluation.
Keywords:
Microemulsion, Valsartan, solubility, evaluationDOI
https://doi.org/10.22270/jddt.v13i10.5990References
Sarkar B, Hardenia S. Microemulsion drug delivery system: For oral bioavailability enhancement of glipizide. J Adv Pharm Educ Res. 2011;1:195-200.
Islam MS, Uddin MI. Development and evaluation of microemulsion formulations of Lornoxicam. Universal Journal of Pharmaceutical Research 2022; 7(6):35-38. https://doi.org/10.22270/ujpr.v7i6.867
Dhamankar A, Manwar J, Kumbhar D. The novel formulation design of O/W microemulsion of ketoprofen for improving transdermal absorption. Int J PharmTech Res. 2009;1:1449-57.
Paliwal S, Kaur G, Arya KKR. Formulation and characterization of topical nano emulgel of terbinafine. Universal Journal of Pharmaceutical Research 2018;3(6):28-34. https://doi.org/10.22270/ujpr.v3i6.223
Naguib G. Microemulsions as vehicles for topical administration of voriconazole: Formulation and in vitro evaluation. Drug Dev Ind Pharm. 2012;38:64-72. https://doi.org/10.3109/03639045.2011.590731 PMid:21696340
Obanewa OA, Oyeniran OT. Development and estimation of anti-inflammatory activity of topical etoricoxib emulgel by carrageenan induced paw oedema method. Universal Journal of Pharmaceutical Research 2019;4(3):22-26.
Cohn JN, Tognoni G. "A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure". The New England Journal of Medicine. 2001;345(23):1667-1675. https://doi.org/10.1056/NEJMoa010713 PMid:11759645
Viberti G, Wheeldon NM. "Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect". Circulation. 2002; 106(6):672-678. https://doi.org/10.1161/01.CIR.0000024416.33113.0A PMid:12163426
Chandra A, Sharma PK, Irchhiaya R. Microemulsion-based hydrogel formulation for transdermal delivery of dexamethasone. Asian J Pharm. 2009;3:30-6. https://doi.org/10.4103/0973-8398.49172
DURGUNME, ALGIN YAPAR E. A critical step for the cosmetic industry: scale-up. Universal Journal of Pharmaceutical Research 2021; 6(3):77-82. https://doi.org/10.22270/ujpr.v6i3.611
Rasal A, Mahajan HS, Shaikh HT, Surana SJ. Development and characterization of nasal mucoadhesive microemulsion of sumatriptan succinate. Indian J Novel Drug Deliv. 2010;2:103-8.
ALGIN YAPAR E, BESKAN U, KARAVANA SY.A recent overview of locally administered topical otic dosage forms. Universal Journal of Pharmaceutical Research 2019; 4(4):39-42. https://doi.org/10.22270/ujpr.v4i4.299
Gibaud S, Attivi D. Microemulsions for oral administration and their therapeutic applications. Expert Opin Drug Deliv. 2012;9:937-51. https://doi.org/10.1517/17425247.2012.694865 PMid:22663249
SHORINWA OA, BENNETH VC. In-vitro antioxidant, lipid peroxidation inhibition and lipid profile modulatory activities of HB Cleanser®bitters in wistar rats. Universal Journal of Pharmaceutical Research 2022; 7(5):68-75.
Bagley DM, Gardner JR, Holland G, Lewis RW, Regnier JF, Stringer DA, et al. Skin irritation: Reference chemicals data bank. Toxicol In vitro. 1996;10:1-6. https://doi.org/10.1016/0887-2333(95)00099-2 PMid:20650176
Edenta C, Ezeaku IN, Zainab A, John DF. Development and evaluation of nanoemulsion formulations for improved oral delivery of carvedilol. Universal Journal of Pharmaceutical Research2017; 2(1): 5-10.
Shah P, Swarnkar D. Development and characterization of microemulsion containing antihypertensive agent using factorial design. J Pharm Bioallied Sci. 2012;4:69-70. https://doi.org/10.4103/0975-7406.94143 PMid:23066212 PMCid:PMC3467821
Islam MS, Mojumder TJ. Development and evaluation of microemulsion formulations of bifonazole. Universal Journal of Pharmaceutical Research 2023; 8(3):45-50. https://doi.org/10.22270/ujpr.v8i3.953
Lee EA, Balakrishnan P, Chng Kil Song CK, Choi JH, Noh GY, Park CG, Choi AJ, Chung SJ, Shim CK, Kim DD. Microemulsion-based hydrogel formulation of itraconazole for topical delivery. J Pharm Invest. 2010; 40:305-11. https://doi.org/10.4333/KPS.2010.40.5.305
Tungadi R, Jusuf H. Formulation and characterization of Astaxanthin Self Nano Emulsifying Drug Delivery System (SNEDDS).Universal Journal of Pharmaceutical Research 2022; 7(3):8-11.
Gohel MC, Nagori SA. Fabrication and evaluation of hydrogel thickened microemulsion of ibuprofen for topical delivery. Indian J Pharm Educ Res. 2010;44:189-96.
Tungadi R, Jusuf H. Formulation and characterization of Astaxanthin Self Nano Emulsifying Drug Delivery System (SNEDDS). Universal Journal of Pharmaceutical Research 2022; 7(3):8-11.
Behera J, Keservani RK, Yadav A, Tripathi M, Chadoker A. Methoxsalen loaded, chitosan coated microemulsion for effective treatment of psoriasis. Int J Drug Deliv. 2010; 2:159-67. https://doi.org/10.5138/ijdd.2010.0975.0215.02025
Published
Abstract Display: 492 
PDF Downloads: 1478 PDF Downloads: 47 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.